ARCHIVES

Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

NCCS Changes Web Domain; NCCN Plans Clinical Trials Network

June 7, 2002

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

July 3, 1981

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Guttmacher Named NICHD Director

December 18, 2009

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985